Arcturus Therapeutics Stock (NASDAQ: ARCT) stock price, news, charts, stock research, profile.
You can purchase shares of Arcturus Therapeutics (NASDAQ:ARCT) through any online brokerage.
Other companies in Arcturus Therapeutics’s space includes: 4D Molecular Therapeutics (NASDAQ:FDMT), Celcuity (NASDAQ:CELC), Altimmune (NASDAQ:ALT), Pharming (NASDAQ:PHAR) and Opthea (NASDAQ:OPT).
Arcturus Therapeutics has a consensus price target of $50.18.
The stock price for Arcturus Therapeutics (NASDAQ: ARCT) is $21.74 last updated September 24, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Arcturus Therapeutics.
Arcturus Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Arcturus Therapeutics.
Arcturus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.